Correlation Between Stryker and Pressure Biosciences
Can any of the company-specific risk be diversified away by investing in both Stryker and Pressure Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Stryker and Pressure Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Stryker and Pressure Biosciences, you can compare the effects of market volatilities on Stryker and Pressure Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Stryker with a short position of Pressure Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Stryker and Pressure Biosciences.
Diversification Opportunities for Stryker and Pressure Biosciences
-0.74 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Stryker and Pressure is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding Stryker and Pressure Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pressure Biosciences and Stryker is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Stryker are associated (or correlated) with Pressure Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pressure Biosciences has no effect on the direction of Stryker i.e., Stryker and Pressure Biosciences go up and down completely randomly.
Pair Corralation between Stryker and Pressure Biosciences
If you would invest 36,715 in Stryker on September 2, 2024 and sell it today you would earn a total of 2,500 from holding Stryker or generate 6.81% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 4.76% |
Values | Daily Returns |
Stryker vs. Pressure Biosciences
Performance |
Timeline |
Stryker |
Pressure Biosciences |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Stryker and Pressure Biosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Stryker and Pressure Biosciences
The main advantage of trading using opposite Stryker and Pressure Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Stryker position performs unexpectedly, Pressure Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pressure Biosciences will offset losses from the drop in Pressure Biosciences' long position.Stryker vs. Profound Medical Corp | Stryker vs. Si Bone | Stryker vs. Nevro Corp | Stryker vs. Orthopediatrics Corp |
Pressure Biosciences vs. ImmuCell | Pressure Biosciences vs. Pro Dex | Pressure Biosciences vs. SANUWAVE Health |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume |